2025-03-11 05:55:29
Latest Post
NTPC Group to Invest Rs 96,000 Crore in Chhattisgarh
Arvind Fashions aims to expand its CLUB A stores across India
Somany Ceramics Elevates Luxury with the launch of Duragres 2025 Collection
Cosmo Films Bags SIES SOP Star Awards 2025 for Innovative Packaging Materials
Zaggle Prepaid Ocean Services Ltd receives 'Financial Institution of the Year' Award
Stock Report
Sanofi India Ltd Q3CY22 net profit at Rs. 130.9 crores
Posted On : 2022-11-03 19:56:16( TIMEZONE : IST )
Sanofi India Limited has reported Standalone financial results for the period ended September 30, 2022.
Financial Results (Q3 CY2022) - QoQ Comparison
The company has reported total income of Rs. 703.3 crores during the period ended September 30, 2022 as compared to Rs. 715 crores during the period ended June 30, 2022.
The company has posted net profit / (loss) of Rs. 130.9 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs. 120.4 crores for the period ended June 30, 2022.
The company has reported EPS of Rs. 56.84 for the period ended September 30, 2022 as compared to Rs. 52.28 for the period ended June 30, 2022.
| Financials | Q3 CY2022 | Q2 CY2022 | % Change |
| Total Income | ₹ 703.3 crs | ₹715 crs |  -1.64% |
| Net Profit | ₹130.9 crs | ₹120.4 crs |  8.72% |
| EPS | ₹56.84 | ₹52.28 | 8.72% |
Financial Results (Q3 CY2022) - YoY Comparison
The company has reported total income of Rs. 703.3 crores during the period ended September 30, 2022 as compared to Rs.769.2 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs.130.9 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs.529.8 crores for the period ended September 30, 2021.
The company has reported EPS of Rs.56.84 for the period ended September 30, 2022 as compared to Rs.230.04 for the period ended September 30, 2021.
| Financials | Q3 CY2022 | Q3 CY2021 | % Change |
| Total Income | ₹ 703.3 crs | ₹769.2 crs | -8.57% |
| Net Profit | ₹130.9 crs | ₹529.8 crs | -75.29% |
| EPS | ₹56.84 | ₹230.04 | -75.29% |
Financial Results (9 Months Ended CY2022) - YoY Comparison
The company has reported total income of Rs.2149.7 crores during the 9 Months period ended September 30, 2022 as compared to Rs.2326.8 crores during the 9 Months period ended September 30, 2021.
The company has posted net profit / (loss) of Rs.489.7 crores for the 9 Months period ended September 30, 2022 as against net profit / (loss) of Rs.854 crores for the 9 Months period ended September 30, 2021.
The company has reported EPS of Rs.212.63 for the 9 Months period ended September 30, 2022 as compared to Rs.370.81 for the 9 Months period ended September 30, 2021.
| Financials | 9 Months Ended CY2022 | 9 Months Ended CY2021 | % Change |
| Total Income | ₹2149.7 crs | ₹2326.8 crs | -7.61% |
| Net Profit | ₹489.7 crs | ₹854 crs | -42.66% |
| EPS | ₹212.63 | ₹370.81 | -42.66% |
Shares of Sanofi India Limited was last trading in BSE at Rs. 5585.20 as compared to the previous close of Rs. 5634.60. The total number of shares traded during the day was 13350 in over 1594 trades.
The stock hit an intraday high of Rs. 5630.45 and intraday low of 5560.00. The net turnover during the day was Rs. 74809065.00.
